首页 > 最新文献

Zhonghua wei zhong bing ji jiu yi xue最新文献

英文 中文
[Development and evaluation of a risk prediction model for sepsis-associated liver injury in the intensive care unit]. [重症监护病房脓毒症相关肝损伤风险预测模型的建立与评价]。
Q3 Medicine Pub Date : 2025-12-01 DOI: 10.3760/cma.j.cn121430-20250531-00529
Hairong Lin, Huizhen Wang
<p><strong>Objective: </strong>To investigate independent risk factors for sepsis-associated liver injury (SALI) in intensive care unit (ICU) patients with sepsis, establish an effective risk prediction model, and validate it.</p><p><strong>Methods: </strong>A retrospective cohort study was conducted using patients diagnosed with sepsis from the Medical Information Mart for Intensive Care IV (MIMIC- IV) v2.2 database. Patients were divided into SALI and non-SALI groups based on the occurrence of SALI. Baseline characteristics, comorbidities, infection sites, vital signs upon ICU admission, initial laboratory parameters within 24 hours of ICU admission, treatment interventions, 24-hour urine output, disease severity scores, and prognostic indicators collected and compared between the two groups. The entire cohort was divided into training and validation sets using a 7 : 3 random sampling ratio. Independent risk factors for SALI occurrence were identified in the training set using least absolute shrinkage and selection operator (LASSO) regression analysis and multivariate Logistic regression analysis. Based on this, a risk prediction model was constructed and presented as a nomogram. Model performance was evaluated in both training and validation sets. Predictive capability was assessed using receiver operator characteristic curve (ROC curve), model calibration was determined via calibration curves, and net benefit was evaluated through decision curve analysis (DCA).</p><p><strong>Results: </strong>The final cohort included 8 549 sepsis patients, comprising 1 067 in the SALI group and 7 482 in the non-SALI group. Significant differences were observed between the two groups regarding gender, type of ICU admission, hypertension, organ failure status, site of infection (bloodstream infection, pulmonary infection, abdominal infection), vital signs, and laboratory tests [white blood cell count (WBC), hemoglobin (Hb), red cell distribution width (RDW), platelet count (PLT), albumin (Alb), total bilirubin (Tbil), aspartate aminotransferase (AST), alanine aminotransferase (ALT), creatinine, blood urea nitrogen, serum calcium, serum potassium, serum sodium, bicarbonate, anion gap (AG), prothrombin time (PT), activated partial thromboplastin time (APTT), international normalized ratio (INR), pH, arterial partial pressure of carbon dioxide (PaCO<sub>2</sub>), lactate], therapeutic interventions [use of albumin, norepinephrine, vasopressin, continuous renal replacement therapy (CRRT), mechanical ventilation, central venous catheterization], 24-hour urine output after ICU admission, disease severity scores, and prognostic indicators were statistically significant (all P < 0.05). After regression analysis screening of these factors in the training set, eight indicators were ultimately included in the predictive model: intra-abdominal infection [odds ratio (OR) = 4.046, 95% confidence interval (95%CI) was 3.236-5.059, P < 0.001], vasopressin (OR = 2.188, 95%CI wa
目的:探讨重症监护病房(ICU)脓毒症患者脓毒症相关性肝损伤(SALI)的独立危险因素,建立有效的风险预测模型,并对其进行验证。方法:对重症监护医学信息市场(MIMIC- IV) v2.2数据库中诊断为脓毒症的患者进行回顾性队列研究。根据SALI发生情况将患者分为SALI组和非SALI组。收集两组患者的基线特征、合并症、感染部位、ICU入院时的生命体征、入院24小时内的初始实验室参数、治疗干预措施、24小时尿量、疾病严重程度评分及预后指标进行比较。采用7:3随机抽样比例将整个队列分为训练组和验证组。使用最小绝对收缩和选择算子(LASSO)回归分析和多变量Logistic回归分析,在训练集中确定SALI发生的独立危险因素。在此基础上,构建了风险预测模型,并以模态图的形式表示。在训练集和验证集中对模型性能进行了评估。采用接收算子特征曲线(ROC曲线)评估预测能力,通过校准曲线确定模型校准,通过决策曲线分析(DCA)评估净效益。结果:最终队列纳入8 549例脓毒症患者,其中SALI组1 067例,非SALI组7 482例。两组患者在性别、ICU入院类型、高血压、脏器功能衰竭状态、感染部位(血流感染、肺部感染、腹部感染)、生命体征、实验室检测指标(白细胞计数(WBC)、血红蛋白(Hb)、红细胞分布宽度(RDW)、血小板计数(PLT)、白蛋白(Alb)、总胆红素(Tbil)、天冬氨酸转氨酶(AST)、丙氨酸转氨酶(ALT)、肌酐、血尿素氮、血钙、血钾、血钠、碳酸氢盐、阴离子间隙(AG)、凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、国际标准化比值(INR)、pH、动脉二氧化碳分压(PaCO2)、乳酸)、治疗干预措施(白蛋白、去甲肾上腺素、加压素、持续肾替代治疗(CRRT)、机械通气、中心静脉置管)、ICU入院后24小时尿量、疾病严重程度评分、预后指标差异均有统计学意义(P < 0.05)。在训练集中对这些因素进行回归分析筛选后,最终将8个指标纳入预测模型:腹腔感染(比值比(或)= 4.046,95%置信区间(95% ci)是3.236 - -5.059,P < 0.001),抗利尿激素(OR = 2.188, 95% ci 1.778 - -2.694, P < 0.001),一般(OR = 1.928, 95% ci 1.506 - -2.469, P < 0.001), RDW (OR = 1.109, 95% ci 1.069 - -1.151, P < 0.001), PLT (OR = 0.996, 95% ci 0.995 - -0.997, P < 0.001), PT (OR = 1.042, 95% ci 1.034 - -1.051, P < 0.001),乳酸(OR = 1.154, 95% ci 1.107 - -1.202, P < 0.001),顺序器官衰竭评估(沙发;OR = 1.119, 95%CI为1.089 ~ 1.150,P < 0.001)。ROC曲线显示,训练集的曲线下面积(AUC)为0.830 (95%CI为0.814-0.847),验证集的曲线下面积为0.847 (95%CI为0.825-0.869)。校准曲线在训练集和验证集上都与理想曲线吻合良好。DCA曲线显示该模型能有效区分有无疾病进展的患者。结论:腹腔感染、抗利尿激素、CRRT、RDW、PLT、PT、乳酸、SOFA评分是脓毒症患者SALI的独立危险因素。基于这些因素构建的SALI预测模型具有一定的临床预测价值。
{"title":"[Development and evaluation of a risk prediction model for sepsis-associated liver injury in the intensive care unit].","authors":"Hairong Lin, Huizhen Wang","doi":"10.3760/cma.j.cn121430-20250531-00529","DOIUrl":"https://doi.org/10.3760/cma.j.cn121430-20250531-00529","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To investigate independent risk factors for sepsis-associated liver injury (SALI) in intensive care unit (ICU) patients with sepsis, establish an effective risk prediction model, and validate it.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A retrospective cohort study was conducted using patients diagnosed with sepsis from the Medical Information Mart for Intensive Care IV (MIMIC- IV) v2.2 database. Patients were divided into SALI and non-SALI groups based on the occurrence of SALI. Baseline characteristics, comorbidities, infection sites, vital signs upon ICU admission, initial laboratory parameters within 24 hours of ICU admission, treatment interventions, 24-hour urine output, disease severity scores, and prognostic indicators collected and compared between the two groups. The entire cohort was divided into training and validation sets using a 7 : 3 random sampling ratio. Independent risk factors for SALI occurrence were identified in the training set using least absolute shrinkage and selection operator (LASSO) regression analysis and multivariate Logistic regression analysis. Based on this, a risk prediction model was constructed and presented as a nomogram. Model performance was evaluated in both training and validation sets. Predictive capability was assessed using receiver operator characteristic curve (ROC curve), model calibration was determined via calibration curves, and net benefit was evaluated through decision curve analysis (DCA).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;The final cohort included 8 549 sepsis patients, comprising 1 067 in the SALI group and 7 482 in the non-SALI group. Significant differences were observed between the two groups regarding gender, type of ICU admission, hypertension, organ failure status, site of infection (bloodstream infection, pulmonary infection, abdominal infection), vital signs, and laboratory tests [white blood cell count (WBC), hemoglobin (Hb), red cell distribution width (RDW), platelet count (PLT), albumin (Alb), total bilirubin (Tbil), aspartate aminotransferase (AST), alanine aminotransferase (ALT), creatinine, blood urea nitrogen, serum calcium, serum potassium, serum sodium, bicarbonate, anion gap (AG), prothrombin time (PT), activated partial thromboplastin time (APTT), international normalized ratio (INR), pH, arterial partial pressure of carbon dioxide (PaCO&lt;sub&gt;2&lt;/sub&gt;), lactate], therapeutic interventions [use of albumin, norepinephrine, vasopressin, continuous renal replacement therapy (CRRT), mechanical ventilation, central venous catheterization], 24-hour urine output after ICU admission, disease severity scores, and prognostic indicators were statistically significant (all P &lt; 0.05). After regression analysis screening of these factors in the training set, eight indicators were ultimately included in the predictive model: intra-abdominal infection [odds ratio (OR) = 4.046, 95% confidence interval (95%CI) was 3.236-5.059, P &lt; 0.001], vasopressin (OR = 2.188, 95%CI wa","PeriodicalId":24079,"journal":{"name":"Zhonghua wei zhong bing ji jiu yi xue","volume":"37 12","pages":"1092-1099"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145918627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Multi-target mechanism and clinical transformation of hyperbaric oxygen therapy in the treatment of hypoxic-ischemic brain injury after cardiopulmonary resuscitation]. [高压氧治疗心肺复苏后缺氧缺血性脑损伤的多靶点机制及临床转化]。
Q3 Medicine Pub Date : 2025-12-01 DOI: 10.3760/cma.j.cn121430-20250605-00317
Yifan Huang, Xiaozhan Yang, Sisen Zhang

Cardiopulmonary resuscitation (CPR) is a critical life-saving intervention for patients who have suffered cardiac arrest (CA), which helps the organism of CA patients to rapidly restore respiratory and circulatory functions. However, the survival rate of patients after CPR is extremely low. Globally, sudden cardiac arrest causes over 3 million deaths annually, and the survival rate after CPR is less than 8%. Hypoxic ischemic brain injury (HIBI) is the primary cause of death in 68% of these cases. Hyperbaric oxygen therapy (HBOT) enhances the dissolution of oxygen in plasma, increases the arterial blood oxygen partial pressure in the body, and improves tissue hypoxia. It is widely used in conditions of cerebral ischemia and hypoxia (such as stroke, CA, etc), but its role in HIBI following CPR has not been fully studied. Therefore, this article systematically reviews the multi-target mechanisms of HBOT in the treatment of HIBI, including the inhibition of cell apoptosis and necrosis, improvement of oxidative stress, reduction of neuroinflammation, and enhancement of blood-brain barrier permeability and collateral circulation. It also discusses emerging treatment strategies such as HBOT combined with gut microbiome modulation and active abdominal compression-decompression CPR (AACD-CPR), exploring their potential as new therapeutic targets for HIBI post-CPR, with the aim of identifying more promising clinical translation paths to improve neurological functional prognosis and quality of life after CPR.

心肺复苏术(CPR)是对心脏骤停(CA)患者至关重要的救命干预手段,它能帮助CA患者机体迅速恢复呼吸和循环功能。然而,心肺复苏术后患者的存活率极低。在全球范围内,心脏骤停每年造成300多万人死亡,心肺复苏术后的存活率不到8%。在这些病例中,缺氧缺血性脑损伤(HIBI)是68%的主要死亡原因。高压氧治疗(HBOT)增强血浆中氧的溶解,提高体内动脉血氧分压,改善组织缺氧。广泛应用于脑缺血、缺氧情况(如卒中、CA等),但其在心肺复苏术后HIBI中的作用尚未得到充分研究。因此,本文系统综述了HBOT治疗HIBI的多靶点机制,包括抑制细胞凋亡和坏死、改善氧化应激、减轻神经炎症、增强血脑屏障通透性和侧支循环。本文还讨论了HBOT联合肠道微生物组调节和主动腹部按压减压心肺复苏术(AACD-CPR)等新兴治疗策略,探索其作为心肺复苏术后HIBI新治疗靶点的潜力,旨在确定更有前景的临床转化途径,以改善心肺复苏术后神经功能预后和生活质量。
{"title":"[Multi-target mechanism and clinical transformation of hyperbaric oxygen therapy in the treatment of hypoxic-ischemic brain injury after cardiopulmonary resuscitation].","authors":"Yifan Huang, Xiaozhan Yang, Sisen Zhang","doi":"10.3760/cma.j.cn121430-20250605-00317","DOIUrl":"10.3760/cma.j.cn121430-20250605-00317","url":null,"abstract":"<p><p>Cardiopulmonary resuscitation (CPR) is a critical life-saving intervention for patients who have suffered cardiac arrest (CA), which helps the organism of CA patients to rapidly restore respiratory and circulatory functions. However, the survival rate of patients after CPR is extremely low. Globally, sudden cardiac arrest causes over 3 million deaths annually, and the survival rate after CPR is less than 8%. Hypoxic ischemic brain injury (HIBI) is the primary cause of death in 68% of these cases. Hyperbaric oxygen therapy (HBOT) enhances the dissolution of oxygen in plasma, increases the arterial blood oxygen partial pressure in the body, and improves tissue hypoxia. It is widely used in conditions of cerebral ischemia and hypoxia (such as stroke, CA, etc), but its role in HIBI following CPR has not been fully studied. Therefore, this article systematically reviews the multi-target mechanisms of HBOT in the treatment of HIBI, including the inhibition of cell apoptosis and necrosis, improvement of oxidative stress, reduction of neuroinflammation, and enhancement of blood-brain barrier permeability and collateral circulation. It also discusses emerging treatment strategies such as HBOT combined with gut microbiome modulation and active abdominal compression-decompression CPR (AACD-CPR), exploring their potential as new therapeutic targets for HIBI post-CPR, with the aim of identifying more promising clinical translation paths to improve neurological functional prognosis and quality of life after CPR.</p>","PeriodicalId":24079,"journal":{"name":"Zhonghua wei zhong bing ji jiu yi xue","volume":"37 12","pages":"1170-1175"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145918690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Evolution and progress of personalized sedation strategies]. [个性化镇静策略的演变与进展]。
Q3 Medicine Pub Date : 2025-12-01 DOI: 10.3760/cma.j.cn121430-20241029-00888
Wenjing Hu, Qingli Dou

Sedation and analgesia strategies are integral components of treatment for critically ill patients. They help to reduce discomfort and anxiety, minimize adverse medical events, enable safe and effective interventions, and ultimately improve patient outcomes. In recent years, with advancing research, the concepts and strategies guiding clinical sedation and analgesia have progressively evolved. Significant shifts have occurred, moving from continuous deep sedation to a model prioritizing analgesia and light sedation, and further to recommendations favoring the use of propofol and dexmedetomidine over benzodiazepines. This series of transitions demonstrates progress in clinical practice. This article will review research on sedation protocols for different patient populations, focusing on the evolution of sedation strategies, comparisons of clinical effects among different sedative agents, the relationships between sedation, delirium, and sleep, and the early comfort using analgesia, minimal sedatives and maximal humane care (eCASH) concept. The aim is to provide a scientific basis for the individualized sedation strategies in clinical practice.

镇静和镇痛策略是治疗危重患者不可或缺的组成部分。它们有助于减少不适和焦虑,最大限度地减少不良医疗事件,实现安全有效的干预,并最终改善患者的预后。近年来,随着研究的深入,指导临床镇静镇痛的概念和策略也在不断发展。已经发生了重大转变,从持续深度镇静转变为优先镇痛和轻度镇静模式,并进一步推荐使用异丙酚和右美托咪定而不是苯二氮卓类药物。这一系列的转变表明了临床实践的进步。本文将回顾不同患者群体的镇静方案研究,重点关注镇静策略的演变,不同镇静药物的临床效果比较,镇静,谵妄和睡眠之间的关系,以及使用镇痛,最小镇静剂和最大人道关怀(eCASH)概念的早期舒适。旨在为临床应用个性化镇静策略提供科学依据。
{"title":"[Evolution and progress of personalized sedation strategies].","authors":"Wenjing Hu, Qingli Dou","doi":"10.3760/cma.j.cn121430-20241029-00888","DOIUrl":"https://doi.org/10.3760/cma.j.cn121430-20241029-00888","url":null,"abstract":"<p><p>Sedation and analgesia strategies are integral components of treatment for critically ill patients. They help to reduce discomfort and anxiety, minimize adverse medical events, enable safe and effective interventions, and ultimately improve patient outcomes. In recent years, with advancing research, the concepts and strategies guiding clinical sedation and analgesia have progressively evolved. Significant shifts have occurred, moving from continuous deep sedation to a model prioritizing analgesia and light sedation, and further to recommendations favoring the use of propofol and dexmedetomidine over benzodiazepines. This series of transitions demonstrates progress in clinical practice. This article will review research on sedation protocols for different patient populations, focusing on the evolution of sedation strategies, comparisons of clinical effects among different sedative agents, the relationships between sedation, delirium, and sleep, and the early comfort using analgesia, minimal sedatives and maximal humane care (eCASH) concept. The aim is to provide a scientific basis for the individualized sedation strategies in clinical practice.</p>","PeriodicalId":24079,"journal":{"name":"Zhonghua wei zhong bing ji jiu yi xue","volume":"37 12","pages":"1164-1169"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145918640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Application of an adjustable facial support pad in prone mechanical ventilation]. [可调节面部支撑垫在俯卧机械通气中的应用]。
Q3 Medicine Pub Date : 2025-12-01 DOI: 10.3760/cma.j.cn121430-20240924-00794
Xiaojie Chen, Bin Li, Yafang Wang, Lin Zhang, Zhimin Zhang, Xinyu Yao

To improve the oxygenation dysfunction in critically ill patients undergoing mechanical ventilation, prone position ventilation has been increasingly adopted. However, it may cause patient discomfort, pressure injuries, facial edema, hemodynamic disturbances, and airway-related complications. To address these issues, the medical staff in the department of critical care medicine at Harrison International Peace Hospital Affiliated to Hebei Medical University, designed an adjustable facial support cushion for prone position ventilation, which has obtained a national utility model patent of China (patent number: ZL 2022 2 3295294.4). This device consists of an extendable support frame, a placement platform, a support platform, a forehead support cushion, bilateral cheek support cushions, a jaw and neck support cushion, an adjustment assembly, and a hook assembly. Patients who received prone position mechanical ventilation in the department of critical care medicine at Harrison International Peace Hospital Affiliated to Hebei Medical University from January 2022 to June 2024 were selected. They were divided into odd-numbered and even-numbered groups according to the order of prone positioning: the odd-numbered group served as the control group and the even-numbered group as the observation group, with 50 cases in each group. The control group used a soft pillow to support the face, while the observation group used a self-made adjustable facial support cushion. General characteristics, incidence of facial pressure injuries, and endotracheal tube displacement were compared between the two groups. Results showed that there were no statistically significant differences in gender, age, or primary diseases between the two groups, making them comparable. The incidence of facial pressure injuries in the observation group was significantly lower than that in the control group [18% (9/50) vs. 68% (34/50), P < 0.05]. Due to the support holes for the endotracheal tube and the hook assembly beneath the support platform of the cushion, the ventilator tubing was prevented from pulling the endotracheal tube by gravity, and thus the incidence of endotracheal tube displacement was significantly lower in the observation group [44% (22/50) vs. 96% (48/50), P < 0.05]. The use of the self-made adjustable facial support cushion can significantly reduce the occurrence of adverse events such as pressure injuries in patients undergoing prone position mechanical ventilation and is worthy of clinical promotion and application.

为改善危重患者机械通气时的氧合功能障碍,越来越多地采用俯卧位通气。然而,它可能引起患者不适、压力损伤、面部水肿、血流动力学紊乱和气道相关并发症。针对这些问题,河北医科大学附属哈里森国际和平医院重症医学科的医护人员设计了一种可调节的俯卧位通气面部支撑垫,并获得了中国国家实用新型专利(专利号:ZL 2022 2 3295294.4)。该装置包括可伸缩支撑架、放置平台、支撑平台、额头支撑垫、双侧脸颊支撑垫、下颌和颈部支撑垫、调节组件和挂钩组件。选择2022年1月至2024年6月在河北医科大学附属哈里森国际和平医院重症医学科接受俯卧位机械通气的患者。按俯卧位顺序分为奇数组和偶数组,奇数组为对照组,偶数组为观察组,每组50例。对照组使用软枕支撑面部,观察组使用自制可调面部支撑垫。比较两组患者的一般特征、面部压伤发生率及气管内管移位情况。结果显示,两组患者在性别、年龄或原发疾病方面没有统计学上的显著差异,具有可比性。观察组颜面压伤发生率显著低于对照组[18%(9/50)比68% (34/50),P < 0.05]。由于气管导管的支撑孔和坐垫支撑平台下方的钩组件,避免了呼吸机气管被重力牵引,因此观察组气管移位的发生率明显低于对照组[44% (22/50)vs. 96% (48/50), P < 0.05]。使用自制的可调节面部支撑垫,可显著减少俯卧位机械通气患者压力损伤等不良事件的发生,值得临床推广应用。
{"title":"[Application of an adjustable facial support pad in prone mechanical ventilation].","authors":"Xiaojie Chen, Bin Li, Yafang Wang, Lin Zhang, Zhimin Zhang, Xinyu Yao","doi":"10.3760/cma.j.cn121430-20240924-00794","DOIUrl":"https://doi.org/10.3760/cma.j.cn121430-20240924-00794","url":null,"abstract":"<p><p>To improve the oxygenation dysfunction in critically ill patients undergoing mechanical ventilation, prone position ventilation has been increasingly adopted. However, it may cause patient discomfort, pressure injuries, facial edema, hemodynamic disturbances, and airway-related complications. To address these issues, the medical staff in the department of critical care medicine at Harrison International Peace Hospital Affiliated to Hebei Medical University, designed an adjustable facial support cushion for prone position ventilation, which has obtained a national utility model patent of China (patent number: ZL 2022 2 3295294.4). This device consists of an extendable support frame, a placement platform, a support platform, a forehead support cushion, bilateral cheek support cushions, a jaw and neck support cushion, an adjustment assembly, and a hook assembly. Patients who received prone position mechanical ventilation in the department of critical care medicine at Harrison International Peace Hospital Affiliated to Hebei Medical University from January 2022 to June 2024 were selected. They were divided into odd-numbered and even-numbered groups according to the order of prone positioning: the odd-numbered group served as the control group and the even-numbered group as the observation group, with 50 cases in each group. The control group used a soft pillow to support the face, while the observation group used a self-made adjustable facial support cushion. General characteristics, incidence of facial pressure injuries, and endotracheal tube displacement were compared between the two groups. Results showed that there were no statistically significant differences in gender, age, or primary diseases between the two groups, making them comparable. The incidence of facial pressure injuries in the observation group was significantly lower than that in the control group [18% (9/50) vs. 68% (34/50), P < 0.05]. Due to the support holes for the endotracheal tube and the hook assembly beneath the support platform of the cushion, the ventilator tubing was prevented from pulling the endotracheal tube by gravity, and thus the incidence of endotracheal tube displacement was significantly lower in the observation group [44% (22/50) vs. 96% (48/50), P < 0.05]. The use of the self-made adjustable facial support cushion can significantly reduce the occurrence of adverse events such as pressure injuries in patients undergoing prone position mechanical ventilation and is worthy of clinical promotion and application.</p>","PeriodicalId":24079,"journal":{"name":"Zhonghua wei zhong bing ji jiu yi xue","volume":"37 12","pages":"1160-1163"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145918548","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Prognostic differences between patients with endogenous and exogenous acute respiratory distress syndrome and the dynamic predictive value of cumulative fluid balance]. [内源性和外源性急性呼吸窘迫综合征患者预后差异及累积体液平衡的动态预测值]。
Q3 Medicine Pub Date : 2025-12-01 DOI: 10.3760/cma.j.cn121430-20250702-00369
Yanni Chen, Xing An, Xigang Ma

Objective: To investigate the differences in prognosis and to analyze the predictive value of cumulative fluid balance at different time points for 28-day mortality in patients with endogenous versus exogenous acute respiratory distress syndrome (ARDS).

Methods: In this retrospective observational study, patients diagnosed with ARDS according to the Berlin definition (2012) and admitted to the department of critical care medicine of the General Hospital of Ningxia Medical University between August 2020 and February 2025 were enrolled. Patient demographics, laboratory parameters, blood gas analyses, tidal volume, positive end expiratory pressure (PEEP), norepinephrine dosage, and disease severity scores were collected. The 28-day ventilator-free days, ICU length of stay, and 28-day survival status were recorded. The cumulative fluid balance was calculated at 3, 5, and 7 days after ICU admission. Based on etiology, patients were categorized into endogenous and exogenous ARDS groups. The Kaplan-Meier method was used to compare 28-day survival rates, and receiver operator characteristic curves (ROC curves) were plotted to assess the predictive value of cumulative fluid balance at 3, 5, and 7 days for 28-day mortality in both groups.

Results: A total of 218 ARDS patients were included, comprising 100 with endogenous ARDS and 118 with exogenous ARDS. Significant differences were observed between the two groups in age, heart rate, activated partial thromboplastin time (APTT), total bilirubin (TBil), C-reactive protein (CRP), procalcitonin (PCT), pH, PEEP, lactate, bicarbonate, and norepinephrine dosage (all P < 0.05). The ICU length of stay was significantly longer in the endogenous ARDS group than in the exogenous ARDS group [days: 11.50 (6.00, 18.00) vs. 8.00 (4.00, 17.25), P < 0.05]. No significant differences were found in 28-day ventilator-free days or 28-day mortality between the two groups. The Kaplan-Meier analysis showed no significant difference in the 28-day survival rate [41.0% (41/100) vs. 54.2% (64/118), P > 0.05]. ROC curve analysis indicated that the cumulative fluid balance at 3, 5, and 7 days had a higher predictive value for 28-day mortality in the exogenous ARDS group compared to the endogenous ARDS group. The most significant predictive performance was observed for the 7-day cumulative fluid balance in the exogenous ARDS group [area under the curve (AUC) = 0.754]. At a cut-off value of 9.42 mL/kg, the sensitivity was 75.93% and the specificity was 71.87%.

Conclusions: Patients with endogenous ARDS had a significantly longer ICU stay than those with exogenous ARDS. The cumulative fluid balance at 3, 5, and 7 days after ICU admission demonstrated a higher predictive value for 28-day mortality in patients with exogenous ARDS.

目的:探讨内源性与外源性急性呼吸窘迫综合征(ARDS)患者的预后差异,分析不同时间点累积体液平衡对ARDS患者28天死亡率的预测价值。方法:本回顾性观察研究纳入2020年8月至2025年2月宁夏医科大学总医院重症医学科收治的符合2012年Berlin定义的ARDS患者。收集患者人口统计学、实验室参数、血气分析、潮气量、呼气末正压(PEEP)、去甲肾上腺素剂量和疾病严重程度评分。记录28天无呼吸机天数、ICU住院天数及28天生存情况。在ICU入院后3、5、7天计算累积体液平衡。根据病因将患者分为内源性和外源性ARDS组。采用Kaplan-Meier法比较28天生存率,绘制受试者操作特征曲线(ROC曲线),评估两组患者3、5、7天累积体液平衡对28天死亡率的预测价值。结果:共纳入218例ARDS患者,其中内源性ARDS 100例,外源性ARDS 118例。两组患者的年龄、心率、活化部分凝血活素时间(APTT)、总胆红素(TBil)、c反应蛋白(CRP)、降钙素原(PCT)、pH、PEEP、乳酸、碳酸氢盐、去甲肾上腺素用量差异均有统计学意义(P < 0.05)。内源性ARDS组ICU住院时间明显长于外源性ARDS组[天数:11.50(6.00,18.00)比8.00 (4.00,17.25),P < 0.05]。两组28天无呼吸机天数和28天死亡率无显著差异。Kaplan-Meier分析显示28天生存率无显著差异[41.0% (41/100)vs. 54.2% (64/118), P < 0.05]。ROC曲线分析显示,与内源性ARDS组相比,外源性ARDS组3、5和7天的累积体液平衡对28天死亡率的预测价值更高。外源性ARDS组7天累积体液平衡的预测效果最为显著[曲线下面积(AUC) = 0.754]。截止值为9.42 mL/kg时,灵敏度为75.93%,特异性为71.87%。结论:内源性ARDS患者的ICU住院时间明显长于外源性ARDS患者。ICU入院后3、5和7天的累积体液平衡对外源性ARDS患者28天死亡率具有较高的预测价值。
{"title":"[Prognostic differences between patients with endogenous and exogenous acute respiratory distress syndrome and the dynamic predictive value of cumulative fluid balance].","authors":"Yanni Chen, Xing An, Xigang Ma","doi":"10.3760/cma.j.cn121430-20250702-00369","DOIUrl":"10.3760/cma.j.cn121430-20250702-00369","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the differences in prognosis and to analyze the predictive value of cumulative fluid balance at different time points for 28-day mortality in patients with endogenous versus exogenous acute respiratory distress syndrome (ARDS).</p><p><strong>Methods: </strong>In this retrospective observational study, patients diagnosed with ARDS according to the Berlin definition (2012) and admitted to the department of critical care medicine of the General Hospital of Ningxia Medical University between August 2020 and February 2025 were enrolled. Patient demographics, laboratory parameters, blood gas analyses, tidal volume, positive end expiratory pressure (PEEP), norepinephrine dosage, and disease severity scores were collected. The 28-day ventilator-free days, ICU length of stay, and 28-day survival status were recorded. The cumulative fluid balance was calculated at 3, 5, and 7 days after ICU admission. Based on etiology, patients were categorized into endogenous and exogenous ARDS groups. The Kaplan-Meier method was used to compare 28-day survival rates, and receiver operator characteristic curves (ROC curves) were plotted to assess the predictive value of cumulative fluid balance at 3, 5, and 7 days for 28-day mortality in both groups.</p><p><strong>Results: </strong>A total of 218 ARDS patients were included, comprising 100 with endogenous ARDS and 118 with exogenous ARDS. Significant differences were observed between the two groups in age, heart rate, activated partial thromboplastin time (APTT), total bilirubin (TBil), C-reactive protein (CRP), procalcitonin (PCT), pH, PEEP, lactate, bicarbonate, and norepinephrine dosage (all P < 0.05). The ICU length of stay was significantly longer in the endogenous ARDS group than in the exogenous ARDS group [days: 11.50 (6.00, 18.00) vs. 8.00 (4.00, 17.25), P < 0.05]. No significant differences were found in 28-day ventilator-free days or 28-day mortality between the two groups. The Kaplan-Meier analysis showed no significant difference in the 28-day survival rate [41.0% (41/100) vs. 54.2% (64/118), P > 0.05]. ROC curve analysis indicated that the cumulative fluid balance at 3, 5, and 7 days had a higher predictive value for 28-day mortality in the exogenous ARDS group compared to the endogenous ARDS group. The most significant predictive performance was observed for the 7-day cumulative fluid balance in the exogenous ARDS group [area under the curve (AUC) = 0.754]. At a cut-off value of 9.42 mL/kg, the sensitivity was 75.93% and the specificity was 71.87%.</p><p><strong>Conclusions: </strong>Patients with endogenous ARDS had a significantly longer ICU stay than those with exogenous ARDS. The cumulative fluid balance at 3, 5, and 7 days after ICU admission demonstrated a higher predictive value for 28-day mortality in patients with exogenous ARDS.</p>","PeriodicalId":24079,"journal":{"name":"Zhonghua wei zhong bing ji jiu yi xue","volume":"37 12","pages":"1115-1119"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145918682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Lactate trajectory-based phenotypes and their association with 28-day mortality in septic cardiomyopathy: a multicenter retrospective cohort study]. [基于乳酸轨迹的表型及其与感染性心肌病28天死亡率的关系:一项多中心回顾性队列研究]。
Q3 Medicine Pub Date : 2025-12-01 DOI: 10.3760/cma.j.cn121430-20250707-00644
Dan Li, Xueyan Wu, Zhenkang Peng, Ying Du, Xianqing Shi, Penglin Ma, Guohui Yang
<p><strong>Objective: </strong>To investigate phenotypic classification based on plasma lactate trajectories and its association with 28-day mortality in patients with septic cardiomyopathy (SCM).</p><p><strong>Methods: </strong>A multicenter retrospective cohort study was conducted. Patients with SCM admitted to the intensive care units (ICUs) of three tertiary hospitals (Affiliated Hospital of Guizhou Medical University, Guizhou Provincial People's Hospital, and GuiQian International Hospital) from October 2019 to December 2024 were enrolled. Baseline characteristics, intervention strategies, and clinical outcomes were collected, including the first blood lactate level upon ICU admission and daily lactate values within 7 days after SCM diagnosis. The primary outcome was 28-day mortality, and secondary outcomes included 28-day vasoactive drug-free days, duration of mechanical ventilation, and ICU length of stay. Latent class growth model (LCGM) was used to identify lactate trajectory-based phenotypes. Differences in the above indicators among phenotypes were compared, and univariate and multivariate Cox regression analyses were performed to identify independent risk factors for 28-day mortality in SCM patients.</p><p><strong>Results: </strong>A total of 216 SCM patients were included, among whom 41 died and 175 survived within 28 days. LCGM identified four lactate trajectory phenotypes: phenotype 1 (persistent low level, n = 142), phenotype 2 (moderate level with rapid decline, n = 32), phenotype 3 (moderate level with slow increase, n = 20), and phenotype 4 (high level with slow decline, n = 22). The 28-day mortality rates of patients in phenotypes 1-4 showed a significant increasing trend (9.2%, 21.9%, 30.0%, and 68.2%, respectively, P < 0.05). Phenotype 1, which exhibited the lowest mortality and lowest acute physiology and chronic health evaluation (APACHE), was designated as the baseline group. Univariate Cox regression analysis showed that phenotypes 3 and 4 were associated with 28-day mortality in SCM patients (both P < 0.05). Multivariate Cox regression analysis revealed that phenotype 3 [hazard ratio (HR) = 2.831, 95% confidence interval (95%CI) was 1.243-6.447] and phenotype 4 (HR = 2.389, 95%CI was 1.223-4.663) were independent risk factors for 28-day mortality (both P < 0.05). Kaplan-Meier survival curves showed that the survival probability gradually flattened after 3 weeks of hospitalization. Using phenotype 1 as the baseline, patients with phenotypes 3 and 4 had a higher risk of death, and the risk in phenotype 4 was significantly higher than that in phenotype 3 (P < 0.05). Accordingly, the four patient groups were stratified into high-risk (high level with slow decline), intermediate-risk (moderate level with slow increase), and low-risk (moderate level with rapid decline and persistent low level) categories.</p><p><strong>Conclusions: </strong>Four phenotypes of SCM were successfully identified based on lactate trajectories, whi
目的:探讨脓毒性心肌病(SCM)患者血浆乳酸轨迹的表型分类及其与28天死亡率的关系。方法:采用多中心回顾性队列研究。选取2019年10月至2024年12月在三家三级医院(贵州医科大学附属医院、贵州省人民医院和贵黔国际医院)重症监护病房(icu)住院的SCM患者。收集基线特征、干预策略和临床结果,包括ICU入院时的首次血乳酸水平和SCM诊断后7天内的每日乳酸值。主要终点是28天死亡率,次要终点包括28天无血管活性药物天数、机械通气持续时间和ICU住院时间。使用潜在类生长模型(LCGM)来确定基于乳酸轨迹的表型。比较上述指标在不同表型间的差异,并进行单因素和多因素Cox回归分析,以确定SCM患者28天死亡率的独立危险因素。结果:共纳入216例SCM患者,其中41例死亡,175例在28 d内存活。LCGM鉴定出四种乳酸轨迹表型:表型1(持续低水平,n = 142),表型2(中等水平,快速下降,n = 32),表型3(中等水平,缓慢上升,n = 20),表型4(高水平,缓慢下降,n = 22)。1 ~ 4型患者28天死亡率呈显著升高趋势(分别为9.2%、21.9%、30.0%、68.2%,P < 0.05)。表型1表现出最低的死亡率和最低的急性生理和慢性健康评估(APACHE),被指定为基线组。单因素Cox回归分析显示,表型3和4与SCM患者28天死亡率相关(均P < 0.05)。多因素Cox回归分析显示,表型3[危险比(HR) = 2.831, 95%可信区间(95% ci)为1.243 ~ 6.447]和表型4 (HR = 2.389, 95% ci为1.223 ~ 4.663)是28天死亡率的独立危险因素(P均< 0.05)。Kaplan-Meier生存曲线显示,住院3周后生存率逐渐趋平。以表型1为基线,表型3、4患者死亡风险较高,且表型4患者死亡风险显著高于表型3患者(P < 0.05)。据此,四组患者分为高危(高水平,缓慢下降)、中危(中度水平,缓慢上升)和低危(中度水平,快速下降,持续低水平)三类。结论:基于乳酸轨迹成功识别出SCM的4种表型,这些表型与28天死亡率密切相关,可用于风险分层,为SCM的预后评估和个体化治疗提供新的见解。
{"title":"[Lactate trajectory-based phenotypes and their association with 28-day mortality in septic cardiomyopathy: a multicenter retrospective cohort study].","authors":"Dan Li, Xueyan Wu, Zhenkang Peng, Ying Du, Xianqing Shi, Penglin Ma, Guohui Yang","doi":"10.3760/cma.j.cn121430-20250707-00644","DOIUrl":"10.3760/cma.j.cn121430-20250707-00644","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To investigate phenotypic classification based on plasma lactate trajectories and its association with 28-day mortality in patients with septic cardiomyopathy (SCM).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A multicenter retrospective cohort study was conducted. Patients with SCM admitted to the intensive care units (ICUs) of three tertiary hospitals (Affiliated Hospital of Guizhou Medical University, Guizhou Provincial People's Hospital, and GuiQian International Hospital) from October 2019 to December 2024 were enrolled. Baseline characteristics, intervention strategies, and clinical outcomes were collected, including the first blood lactate level upon ICU admission and daily lactate values within 7 days after SCM diagnosis. The primary outcome was 28-day mortality, and secondary outcomes included 28-day vasoactive drug-free days, duration of mechanical ventilation, and ICU length of stay. Latent class growth model (LCGM) was used to identify lactate trajectory-based phenotypes. Differences in the above indicators among phenotypes were compared, and univariate and multivariate Cox regression analyses were performed to identify independent risk factors for 28-day mortality in SCM patients.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 216 SCM patients were included, among whom 41 died and 175 survived within 28 days. LCGM identified four lactate trajectory phenotypes: phenotype 1 (persistent low level, n = 142), phenotype 2 (moderate level with rapid decline, n = 32), phenotype 3 (moderate level with slow increase, n = 20), and phenotype 4 (high level with slow decline, n = 22). The 28-day mortality rates of patients in phenotypes 1-4 showed a significant increasing trend (9.2%, 21.9%, 30.0%, and 68.2%, respectively, P &lt; 0.05). Phenotype 1, which exhibited the lowest mortality and lowest acute physiology and chronic health evaluation (APACHE), was designated as the baseline group. Univariate Cox regression analysis showed that phenotypes 3 and 4 were associated with 28-day mortality in SCM patients (both P &lt; 0.05). Multivariate Cox regression analysis revealed that phenotype 3 [hazard ratio (HR) = 2.831, 95% confidence interval (95%CI) was 1.243-6.447] and phenotype 4 (HR = 2.389, 95%CI was 1.223-4.663) were independent risk factors for 28-day mortality (both P &lt; 0.05). Kaplan-Meier survival curves showed that the survival probability gradually flattened after 3 weeks of hospitalization. Using phenotype 1 as the baseline, patients with phenotypes 3 and 4 had a higher risk of death, and the risk in phenotype 4 was significantly higher than that in phenotype 3 (P &lt; 0.05). Accordingly, the four patient groups were stratified into high-risk (high level with slow decline), intermediate-risk (moderate level with slow increase), and low-risk (moderate level with rapid decline and persistent low level) categories.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;Four phenotypes of SCM were successfully identified based on lactate trajectories, whi","PeriodicalId":24079,"journal":{"name":"Zhonghua wei zhong bing ji jiu yi xue","volume":"37 12","pages":"1085-1091"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145918574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Agmatine alleviates sepsis-induced intestinal injury by modulating the nuclear factor-ΚB signaling pathway through immunoglobulin superfamily containing leucine rich repeat to suppress intestinal pyroptosis]. [Agmatine通过富含亮氨酸重复序列的免疫球蛋白超家族调节核因子-ΚB信号通路抑制肠道焦亡,减轻脓毒症诱导的肠道损伤]。
Q3 Medicine Pub Date : 2025-12-01 DOI: 10.3760/cma.j.cn121430-20250730-00411
Enping Zhang, Yu Tian, Bo Yang, Tao Chen
<p><strong>Objective: </strong>To investigate the mechanism by which agmatine alleviates sepsis-induced intestinal injury through the inhibition of intestinal pyroptosis.</p><p><strong>Methods: </strong>1) Bioinformatic analysis: Dataset GSE13904 was selected from the gene expression omnibus (GEO) database, gene ontology (GO), Kyoto encyclopedia of genes and genomes database (KEGG), and protein-protein interaction (PPI) analyses were performed to analyze transcriptomic changes in the blood of sepsis patients. 2) Animal experiments: Ten C57BL/6J mice were randomly divided into a sham group (laparotomy only without ligation) and a sepsis-induced intestinal injury model group [cecal ligation and puncture (CLP)], with 5 mice in each group. Mice were euthanized 48 hours after successful modeling, and ileal tissues were harvested. The expression of immunoglobulin superfamily containing leucine rich repeat (ISLR) in the intestinal tissues of mice was detected by quantitative polymerase chain reaction (qPCR) and Western blotting. 3) Cell experiments: ICE-6 cells were divided into the following groups: control group (cultured in complete medium), lipopolysaccharide (LPS) group (cultured in complete medium containing 10 mg/L lipopolysaccharide, LPS), LPS+agmatine group (treated with 120 μmol/L agmatine on the basis of the LPS group), and an LPS+agmatine+siRNA-ISLR group [transfected with small interfering RNA (siRNA)-ISLR on the basis of the LPS + agmatine group]. Furthermore, cells transfected with siRNA negative control (siRNA-NC) were used to verify the silencing effect of siRNA-ISLR on the ISLR gene. ICE-6 cells were divided into a control group, an LPS group, an LPS+agmatine group, and an LPS+agmatine+Aconine group [treated with 0.25 mmol/L Aconine, a nuclear factor-κB (NF-κB) signaling activator, on the basis of the LPS + agmatine group]. The expression levels of ISLR, NOD-like receptor protein 3 (NLRP3), interleukin-1β (IL-1β), and caspase-1 in cells from each group were detected by qPCR and Western blotting. The levels of IL-6, IL-1β, and tumor necrosis factor-α (TNF-α) in the cell supernatants were measured by enzyme-linked immunosorbent assay (ELISA).</p><p><strong>Results: </strong>1) Bioinformatic analysis: GO, KEGG, and PPI analyses of dataset GSE13904 revealed abnormal expression of multiple molecules in sepsis patients, among which ISLR expression was significantly decreased. 2) Animal experiments: The expression levels of ISLR in the intestinal tissue of mice in the sepsis-induced intestinal injury model group were significantly lower than those in the sham group [ISLR mRNA (2<sup>-ΔΔCt</sup>): 0.52±0.12 vs. 1.02±0.21; ISLR/GAPDH: 0.55±0.01 vs. 1.00±0.01, both P < 0.05], which was consistent with the trend observed in the bioinformatic analysis; therefore, ISLR was selected as the target molecule for functional and mechanistic investigation. 3) Cell experiments: Compared with the control and siRNA-NC groups, ISLR expression was downregulate
目的:探讨胍丁胺通过抑制肠道焦亡减轻脓毒症所致肠道损伤的机制。方法:1)生物信息学分析:从基因表达综合数据库(GEO)、基因本体(GO)、京都基因与基因组百科全书数据库(KEGG)中选取数据集GSE13904,进行蛋白-蛋白相互作用(PPI)分析,分析脓毒症患者血液转录组学变化。2)动物实验:将10只C57BL/6J小鼠随机分为假手术组(仅开腹不结扎)和脓毒症肠损伤模型组[盲肠结扎穿刺(CLP)],每组5只。造模成功后48小时对小鼠实施安乐死,取回肠组织。采用定量聚合酶链式反应(qPCR)和Western blotting检测小鼠肠道组织中含有富亮氨酸重复序列(ISLR)的免疫球蛋白超家族的表达。3)细胞实验:将ICE-6细胞分为对照组(在完全培养液中培养)、脂多糖(LPS)组(在含10 mg/L脂多糖的完全培养液中培养)、LPS+agmatine组(在LPS组的基础上用120 μmol/L的agmatine处理)、LPS+agmatine+siRNA-ISLR组[在LPS+agmatine组的基础上转染小干扰RNA (siRNA)-ISLR]。此外,用转染siRNA阴性对照(siRNA- nc)的细胞验证siRNA-ISLR对ISLR基因的沉默作用。将ICE-6细胞分为对照组、LPS组、LPS+agmatine组、LPS+agmatine+Aconine组[在LPS+agmatine组的基础上,给予0.25 mmol/L核因子-κB (NF-κB)信号激活剂Aconine处理]。采用qPCR和Western blotting检测各组细胞中ISLR、nod样受体蛋白3 (NLRP3)、白细胞介素-1β (IL-1β)、caspase-1的表达水平。采用酶联免疫吸附法(ELISA)检测细胞上清液中IL-6、IL-1β、肿瘤坏死因子-α (TNF-α)水平。结果:1)生物信息学分析:对数据集GSE13904进行GO、KEGG和PPI分析,发现脓毒症患者中有多个分子表达异常,其中ISLR表达明显降低。2)动物实验:脓毒症肠损伤模型组小鼠肠组织中ISLR的表达水平显著低于假手术组[ISLR mRNA (2-ΔΔCt): 0.52±0.12∶1.02±0.21;ISLR/GAPDH: 0.55±0.01 vs. 1.00±0.01,P均< 0.05],与生物信息学分析结果一致;因此,选择ISLR作为功能和机制研究的靶分子。3)细胞实验:与对照组和siRNA-NC组相比,siRNA-ISLR组ISLR表达下调,证实ISLR基因成功特异性敲除。与对照组比较,LPS组大鼠ISLR表达显著下调,NLRP3、IL-1β、caspase-1表达显著上调,上清液中IL-6、IL-1β、TNF-α水平显著升高(均P < 0.05), LPS诱导的损伤模型建立成功。与LPS组比较,LPS+agmatine组ISLR表达显著上调[ISLR mRNA (2-ΔΔCt): 0.98±0.17比0.48±0.11,ISLR/GAPDH: 0.95±0.08比0.71±0.05],NLRP3、IL-1β、caspase-1表达显著下调,上清液中IL-6、IL-1β、TNF-α水平显著降低(均P < 0.05)。与LPS+agmatine组比较,LPS+agmatine+siRNA-ISLR组[ISLR mRNA (2-ΔΔCt): 0.62±0.20比0.98±0.17,ISLR/GAPDH: 0.68±0.03比0.95±0.08]和LPS+agmatine+Aconine组[ISLR mRNA (2-ΔΔCt): 0.28±0.05比0.97±0.31,ISLR/GAPDH:(0.61±0.03 vs. 0.93±0.03),NLRP3、IL-1β、caspase-1表达显著上调,上清液中IL-6、IL-1β、TNF-α水平显著升高(均P < 0.05),提示siRNA-ISLR或NF-κB信号激活剂可逆转agmatine的作用。结论:胍丁胺可能通过抑制肠细胞热亡而减轻脓毒症诱导的肠细胞损伤,其机制可能是通过ISLR调节NF-κB信号通路。
{"title":"[Agmatine alleviates sepsis-induced intestinal injury by modulating the nuclear factor-ΚB signaling pathway through immunoglobulin superfamily containing leucine rich repeat to suppress intestinal pyroptosis].","authors":"Enping Zhang, Yu Tian, Bo Yang, Tao Chen","doi":"10.3760/cma.j.cn121430-20250730-00411","DOIUrl":"https://doi.org/10.3760/cma.j.cn121430-20250730-00411","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To investigate the mechanism by which agmatine alleviates sepsis-induced intestinal injury through the inhibition of intestinal pyroptosis.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;1) Bioinformatic analysis: Dataset GSE13904 was selected from the gene expression omnibus (GEO) database, gene ontology (GO), Kyoto encyclopedia of genes and genomes database (KEGG), and protein-protein interaction (PPI) analyses were performed to analyze transcriptomic changes in the blood of sepsis patients. 2) Animal experiments: Ten C57BL/6J mice were randomly divided into a sham group (laparotomy only without ligation) and a sepsis-induced intestinal injury model group [cecal ligation and puncture (CLP)], with 5 mice in each group. Mice were euthanized 48 hours after successful modeling, and ileal tissues were harvested. The expression of immunoglobulin superfamily containing leucine rich repeat (ISLR) in the intestinal tissues of mice was detected by quantitative polymerase chain reaction (qPCR) and Western blotting. 3) Cell experiments: ICE-6 cells were divided into the following groups: control group (cultured in complete medium), lipopolysaccharide (LPS) group (cultured in complete medium containing 10 mg/L lipopolysaccharide, LPS), LPS+agmatine group (treated with 120 μmol/L agmatine on the basis of the LPS group), and an LPS+agmatine+siRNA-ISLR group [transfected with small interfering RNA (siRNA)-ISLR on the basis of the LPS + agmatine group]. Furthermore, cells transfected with siRNA negative control (siRNA-NC) were used to verify the silencing effect of siRNA-ISLR on the ISLR gene. ICE-6 cells were divided into a control group, an LPS group, an LPS+agmatine group, and an LPS+agmatine+Aconine group [treated with 0.25 mmol/L Aconine, a nuclear factor-κB (NF-κB) signaling activator, on the basis of the LPS + agmatine group]. The expression levels of ISLR, NOD-like receptor protein 3 (NLRP3), interleukin-1β (IL-1β), and caspase-1 in cells from each group were detected by qPCR and Western blotting. The levels of IL-6, IL-1β, and tumor necrosis factor-α (TNF-α) in the cell supernatants were measured by enzyme-linked immunosorbent assay (ELISA).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;1) Bioinformatic analysis: GO, KEGG, and PPI analyses of dataset GSE13904 revealed abnormal expression of multiple molecules in sepsis patients, among which ISLR expression was significantly decreased. 2) Animal experiments: The expression levels of ISLR in the intestinal tissue of mice in the sepsis-induced intestinal injury model group were significantly lower than those in the sham group [ISLR mRNA (2&lt;sup&gt;-ΔΔCt&lt;/sup&gt;): 0.52±0.12 vs. 1.02±0.21; ISLR/GAPDH: 0.55±0.01 vs. 1.00±0.01, both P &lt; 0.05], which was consistent with the trend observed in the bioinformatic analysis; therefore, ISLR was selected as the target molecule for functional and mechanistic investigation. 3) Cell experiments: Compared with the control and siRNA-NC groups, ISLR expression was downregulate","PeriodicalId":24079,"journal":{"name":"Zhonghua wei zhong bing ji jiu yi xue","volume":"37 12","pages":"1100-1108"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145918629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Predictive value of combined detection of pro-opiomelanocortin and α-melanocyte stimulating hormone for progression to persistent inflammation, immunosuppression, and catabolism syndrome in critical patients]. [联合检测促阿皮质素和α-促黑素细胞激素对危重患者进展为持续性炎症、免疫抑制和分解代谢综合征的预测价值]。
Q3 Medicine Pub Date : 2025-12-01 DOI: 10.3760/cma.j.cn121430-20240911-00446
Jiawen Chen, Xiancheng Chen, Haoran Li, Jiali Liu, Minhua Cheng, Jianfeng Duan, Zhanghua Zhu, Wenkui Yu

Objective: To investigate the predictive value of combined detection of pro-opiomelanocortin (POMC) and α-melanocyte stimulating hormone (α-MSH) for progression to persistent inflammation, immunosuppression, and catabolism syndrome (PIICS) in critical patients.

Methods: A retrospective cohort study was conducted, including critical patients admitted to the intensive care unit (ICU) of Nanjing Drum Tower Hospital between March 2020 and July 2021. Baseline data were collected, encompassing gender, age, infection source, smoking history, alcohol consumption history, and underlying diseases. On the first day of ICU admission, sequential organ failure assessment (SOFA), acute physiology and chronic health evaluation II(APACHE II), serum POMC and α-MSH levels were recorded, along with the incidence of PIICS during ICU stay. Spearman correlation analysis was used to evaluate the correlation between POMC and α-MSH levels and disease severity. Receiver operator characteristic curve (ROC curve) was constructed to evaluate the predictive accuracy of POMC and α-MSH for PIICS progression.

Results: A total of 63 critical patients were included, among whom 47 (75%) developed PIICS and 16 (25%) did not. Compared with the non-PIICS group, the PIICS group showed significantly higher APACHE II and SOFA scores, while no statistical differences were observed in other baseline characteristics. The POMC level on the first day of ICU admission was significantly higher in the PIICS group than in the non-PIICS group, while the α-MSH level showed the opposite trend [POMC (ng/L): 2 149.02 (1 939.54, 2 761.06) vs. 1 884.73 (1 651.83, 2 234.99), α-MSH (ng/L): 1 526.95 (982.84, 2 092.94) vs. 2 182.76 (1 500.57, 3 401.51), both P < 0.05]. Spearman correlation analysis demonstrated that the serum POMC level at admission to the ICU was positively correlated with the SOFA score and the occurrence of PIICS (with r values of 0.275 and 0.279, respectively, both P < 0.05). In contrast, the α-MSH level was negatively correlated with the APACHE II score, SOFA score, and the occurrence of PIICS (with r values of -0.291, -0.339, and -0.287, respectively, all P < 0.05). ROC curve analysis demonstrated that both POMC and α-MSH had certain predictive value for the progression of critical patients to PIICS. The predictive value was the greatest when POMC and α-MSH were detected in combination, area under the curve (AUC) was 0.743, with the sensitivity and specificity for predicting PIICS being 87.2% and 50.0%, respectively.

Conclusions: The combined detection of POMC and α-MSH on the first day of ICU admission showed certain predictive value for the progression of critical patients to PIICS.

目的:探讨联合检测促黑素促黑素素(POMC)和α-促黑素细胞激素(α-MSH)对危重患者进展为持续性炎症、免疫抑制和分解代谢综合征(PIICS)的预测价值。方法:采用回顾性队列研究,选取2020年3月至2021年7月南京鼓楼医院重症监护病房(ICU)收治的危重患者。收集基线数据,包括性别、年龄、感染来源、吸烟史、饮酒史和基础疾病。入院第1天,记录患者顺序脏器功能衰竭评价(SOFA)、急性生理与慢性健康评价ⅱ(APACHEⅱ)、血清POMC、α-MSH水平,以及住院期间PIICS的发生情况。采用Spearman相关分析评价POMC、α-MSH水平与病情严重程度的相关性。构建ROC曲线(Receiver operator characteristic curve),评价POMC和α-MSH对PIICS进展的预测准确性。结果:共纳入63例危重患者,其中47例(75%)发生PIICS, 16例(25%)未发生PIICS。与非PIICS组相比,PIICS组的APACHE II和SOFA评分明显高于非PIICS组,而其他基线特征无统计学差异。PIICS组患者入院第1天POMC水平明显高于非PIICS组,α-MSH水平则相反[POMC (ng/L): 2 149.02(1 939.54, 2 761.06)比1 884.73 (1 651.83,2 234.99),α-MSH (ng/L): 1 526.95(982.84, 2 092.94)比2 182.76 (1 500.57,3 401.51),P均< 0.05]。Spearman相关分析显示,入院时血清POMC水平与SOFA评分、PIICS发生呈正相关(r值分别为0.275、0.279,P均< 0.05)。α-MSH水平与APACHEⅱ评分、SOFA评分、PIICS发生呈负相关(r值分别为-0.291、-0.339、-0.287,P均< 0.05)。ROC曲线分析表明,POMC和α-MSH对危重患者向PIICS进展均有一定的预测价值。POMC和α-MSH联合检测的预测值最高,曲线下面积(AUC)为0.743,预测PIICS的敏感性和特异性分别为87.2%和50.0%。结论:ICU入院第1天POMC和α-MSH联合检测对危重患者向PIICS发展具有一定的预测价值。
{"title":"[Predictive value of combined detection of pro-opiomelanocortin and α-melanocyte stimulating hormone for progression to persistent inflammation, immunosuppression, and catabolism syndrome in critical patients].","authors":"Jiawen Chen, Xiancheng Chen, Haoran Li, Jiali Liu, Minhua Cheng, Jianfeng Duan, Zhanghua Zhu, Wenkui Yu","doi":"10.3760/cma.j.cn121430-20240911-00446","DOIUrl":"https://doi.org/10.3760/cma.j.cn121430-20240911-00446","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the predictive value of combined detection of pro-opiomelanocortin (POMC) and α-melanocyte stimulating hormone (α-MSH) for progression to persistent inflammation, immunosuppression, and catabolism syndrome (PIICS) in critical patients.</p><p><strong>Methods: </strong>A retrospective cohort study was conducted, including critical patients admitted to the intensive care unit (ICU) of Nanjing Drum Tower Hospital between March 2020 and July 2021. Baseline data were collected, encompassing gender, age, infection source, smoking history, alcohol consumption history, and underlying diseases. On the first day of ICU admission, sequential organ failure assessment (SOFA), acute physiology and chronic health evaluation II(APACHE II), serum POMC and α-MSH levels were recorded, along with the incidence of PIICS during ICU stay. Spearman correlation analysis was used to evaluate the correlation between POMC and α-MSH levels and disease severity. Receiver operator characteristic curve (ROC curve) was constructed to evaluate the predictive accuracy of POMC and α-MSH for PIICS progression.</p><p><strong>Results: </strong>A total of 63 critical patients were included, among whom 47 (75%) developed PIICS and 16 (25%) did not. Compared with the non-PIICS group, the PIICS group showed significantly higher APACHE II and SOFA scores, while no statistical differences were observed in other baseline characteristics. The POMC level on the first day of ICU admission was significantly higher in the PIICS group than in the non-PIICS group, while the α-MSH level showed the opposite trend [POMC (ng/L): 2 149.02 (1 939.54, 2 761.06) vs. 1 884.73 (1 651.83, 2 234.99), α-MSH (ng/L): 1 526.95 (982.84, 2 092.94) vs. 2 182.76 (1 500.57, 3 401.51), both P < 0.05]. Spearman correlation analysis demonstrated that the serum POMC level at admission to the ICU was positively correlated with the SOFA score and the occurrence of PIICS (with r values of 0.275 and 0.279, respectively, both P < 0.05). In contrast, the α-MSH level was negatively correlated with the APACHE II score, SOFA score, and the occurrence of PIICS (with r values of -0.291, -0.339, and -0.287, respectively, all P < 0.05). ROC curve analysis demonstrated that both POMC and α-MSH had certain predictive value for the progression of critical patients to PIICS. The predictive value was the greatest when POMC and α-MSH were detected in combination, area under the curve (AUC) was 0.743, with the sensitivity and specificity for predicting PIICS being 87.2% and 50.0%, respectively.</p><p><strong>Conclusions: </strong>The combined detection of POMC and α-MSH on the first day of ICU admission showed certain predictive value for the progression of critical patients to PIICS.</p>","PeriodicalId":24079,"journal":{"name":"Zhonghua wei zhong bing ji jiu yi xue","volume":"37 12","pages":"1156-1159"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145918742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Application of electrical impedance tomography technology in the study of awake prone position ventilation in elderly acute respiratory distress syndrome patient]. [电阻抗断层扫描技术在老年急性呼吸窘迫综合征患者清醒俯卧位通气中的应用]。
Q3 Medicine Pub Date : 2025-12-01 DOI: 10.3760/cma.j.cn121430-20250324-00290
Shenghao Gao, Haibo Wang, Ting Zhang, Xiaoju Zhang, Tengteng Zhang, Taibo Huang, Zhenyu Li, Xuanxuan Li, Dongping Wang, Shaoshuai Cui, Jianjian Cheng
<p><strong>Objective: </strong>To observe changes in blood gas analysis and lung ventilation using electrical impedance tomography (EIT) in elderly patients with mild to moderate acute respiratory distress syndrome (ARDS) undergoing awake prone position ventilation (APPV), and to evaluate the rate of tracheal intubation.</p><p><strong>Methods: </strong>A randomized controlled study was conducted, involving 58 elderly patients with mild to moderate ARDS admitted to the respiratory intensive care unit (RICU) of Henan Provincial People's Hospital from August 2022 to April 2023. Patients were randomly divided into a control group (n = 27) and an experimental group (n = 31) using a random number table. The control group received conventional treatments, including sputum suction, anti-infection therapy, and non-invasive ventilation. The experimental group received additional prone position therapy. The gender, age, heart rate (HR), respiratory rate (RR), pH value, arterial partial pressure of carbon dioxide (PaCO<sub>2</sub>), oxygenation index (PaO<sub>2</sub>/FiO<sub>2</sub>), acute physiology and chronic health evaluation II (APACHE II), and regional ventilation values (ROIs 1-4) at baseline and on days 1, 3, 5, and 7 were collected and compared between the two groups. The 7-day tracheal intubation rate was also recorded and analyzed.</p><p><strong>Results: </strong>There were no statistically significant differences in gender, age, HR, RR, pH value, PaCO<sub>2</sub>, PaO<sub>2</sub>/FiO<sub>2</sub>, and APACHE II scores between the two groups of patients at the time of enrollment. After intervention, both groups showed varying degrees of improvement in RR and the PaO<sub>2</sub>/FiO<sub>2</sub>, with the rate of improvement slowing after day 5, and the experimental group demonstrated more significant improvements in the PaO<sub>2</sub>/FiO<sub>2</sub> (P < 0.05 for group, time, and group-time interaction). In terms of lung ventilation ROIs, the ROI 1 and ROI 2 values in both groups gradually decreased over time, while the ROI 3 and ROI 4 values increased. The magnitude of change in the experimental group was greater than in the control group, which showed limited improvement during the same period. significant time effects were found for ROI 1-4 values over time in both groups (time effect: F = 25.364, 21.475, 39.895, 41.579, all P < 0.05). and significant group effects were observed for ROI 2 and ROI 3 values (group effect: F = 4.481 and 11.409, both P < 0.05). On day 1, the experimental group showed significant improvements in ROI 1-3 values compared to the control group (F = 10.536, 25.637, 28.451, all P < 0.05). By day 3, significant differences were observed in ROI 1-4 values between the two groups (F = 6.356, 25.734, 23.678, 19.254, all P < 0.05). On day 5, gas distribution in lung tissues became more uniform in the experimental group, with statistically significant differences in ROI 1-4 values (F = 8.342 and 18.345, both P < 0.05). By day 7
目的:观察老年轻中度急性呼吸窘迫综合征(ARDS)患者行清醒俯卧位通气(APPV)时血气分析及肺通气的变化,并评价其气管插管率。方法:对2022年8月至2023年4月在河南省人民医院呼吸重症监护室(RICU)住院的58例轻中度ARDS老年患者进行随机对照研究。采用随机数字表法将患者随机分为对照组(27例)和实验组(31例)。对照组患者给予吸痰、抗感染、无创通气等常规治疗。实验组患者在对照组基础上进行俯卧位治疗。收集两组患者基线及第1、3、5、7天的性别、年龄、心率(HR)、呼吸频率(RR)、pH值、动脉二氧化碳分压(PaCO2)、氧合指数(PaO2/FiO2)、急性生理和慢性健康评估II (APACHE II)、区域通气值(roi 1 ~ 4)进行比较。记录并分析7 d气管插管率。结果:入组时两组患者性别、年龄、HR、RR、pH值、PaCO2、PaO2/FiO2、APACHE II评分差异均无统计学意义。干预后,两组患者RR及PaO2/FiO2均有不同程度改善,第5天改善速度减慢,实验组患者PaO2/FiO2改善更为显著(组间、时间及组间交互作用P < 0.05)。在肺通气ROI方面,两组的ROI 1和ROI 2值随着时间的推移逐渐降低,而ROI 3和ROI 4值逐渐升高。实验组的变化幅度大于对照组,对照组同期改善有限。两组ROI 1-4值随时间的变化均存在显著的时间效应(时间效应:F = 25.364、21.475、39.895、41.579,P均< 0.05)。ROI 2、ROI 3值组效应显著(组效应:F = 4.481、11.409,P均< 0.05)。第1天,实验组ROI 1-3值较对照组有显著提高(F = 10.536, 25.637, 28.451, P均< 0.05)。第3天,两组ROI 1-4值比较,差异有统计学意义(F = 6.356、25.734、23.678、19.254,P均< 0.05)。第5天,实验组肺组织气体分布更加均匀,ROI 1 ~ 4值差异有统计学意义(F = 8.342、18.345,P均< 0.05)。第7天,实验组重力依赖肺区通气分布较好,ROI 3、ROI 4值与对照组比较差异有统计学意义(F = 6.820、7.350,P均< 0.05)。实验组7天气管插管率显著低于对照组[32.3%(10/31)比52% (14/27),P < 0.05]。结论:老年轻中度ARDS患者应用APPV可改善PaO2/FiO2,增强局部肺通气均匀性,降低气管插管率。
{"title":"[Application of electrical impedance tomography technology in the study of awake prone position ventilation in elderly acute respiratory distress syndrome patient].","authors":"Shenghao Gao, Haibo Wang, Ting Zhang, Xiaoju Zhang, Tengteng Zhang, Taibo Huang, Zhenyu Li, Xuanxuan Li, Dongping Wang, Shaoshuai Cui, Jianjian Cheng","doi":"10.3760/cma.j.cn121430-20250324-00290","DOIUrl":"10.3760/cma.j.cn121430-20250324-00290","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To observe changes in blood gas analysis and lung ventilation using electrical impedance tomography (EIT) in elderly patients with mild to moderate acute respiratory distress syndrome (ARDS) undergoing awake prone position ventilation (APPV), and to evaluate the rate of tracheal intubation.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A randomized controlled study was conducted, involving 58 elderly patients with mild to moderate ARDS admitted to the respiratory intensive care unit (RICU) of Henan Provincial People's Hospital from August 2022 to April 2023. Patients were randomly divided into a control group (n = 27) and an experimental group (n = 31) using a random number table. The control group received conventional treatments, including sputum suction, anti-infection therapy, and non-invasive ventilation. The experimental group received additional prone position therapy. The gender, age, heart rate (HR), respiratory rate (RR), pH value, arterial partial pressure of carbon dioxide (PaCO&lt;sub&gt;2&lt;/sub&gt;), oxygenation index (PaO&lt;sub&gt;2&lt;/sub&gt;/FiO&lt;sub&gt;2&lt;/sub&gt;), acute physiology and chronic health evaluation II (APACHE II), and regional ventilation values (ROIs 1-4) at baseline and on days 1, 3, 5, and 7 were collected and compared between the two groups. The 7-day tracheal intubation rate was also recorded and analyzed.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;There were no statistically significant differences in gender, age, HR, RR, pH value, PaCO&lt;sub&gt;2&lt;/sub&gt;, PaO&lt;sub&gt;2&lt;/sub&gt;/FiO&lt;sub&gt;2&lt;/sub&gt;, and APACHE II scores between the two groups of patients at the time of enrollment. After intervention, both groups showed varying degrees of improvement in RR and the PaO&lt;sub&gt;2&lt;/sub&gt;/FiO&lt;sub&gt;2&lt;/sub&gt;, with the rate of improvement slowing after day 5, and the experimental group demonstrated more significant improvements in the PaO&lt;sub&gt;2&lt;/sub&gt;/FiO&lt;sub&gt;2&lt;/sub&gt; (P &lt; 0.05 for group, time, and group-time interaction). In terms of lung ventilation ROIs, the ROI 1 and ROI 2 values in both groups gradually decreased over time, while the ROI 3 and ROI 4 values increased. The magnitude of change in the experimental group was greater than in the control group, which showed limited improvement during the same period. significant time effects were found for ROI 1-4 values over time in both groups (time effect: F = 25.364, 21.475, 39.895, 41.579, all P &lt; 0.05). and significant group effects were observed for ROI 2 and ROI 3 values (group effect: F = 4.481 and 11.409, both P &lt; 0.05). On day 1, the experimental group showed significant improvements in ROI 1-3 values compared to the control group (F = 10.536, 25.637, 28.451, all P &lt; 0.05). By day 3, significant differences were observed in ROI 1-4 values between the two groups (F = 6.356, 25.734, 23.678, 19.254, all P &lt; 0.05). On day 5, gas distribution in lung tissues became more uniform in the experimental group, with statistically significant differences in ROI 1-4 values (F = 8.342 and 18.345, both P &lt; 0.05). By day 7","PeriodicalId":24079,"journal":{"name":"Zhonghua wei zhong bing ji jiu yi xue","volume":"37 12","pages":"1109-1114"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145918551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Effect of serum magnesium on mortality in intensive care unit patients with heart failure: a retrospective analysis based on the MIMIC-III database]. [血清镁对重症监护病房心力衰竭患者死亡率的影响:基于MIMIC-III数据库的回顾性分析]。
Q3 Medicine Pub Date : 2025-12-01 DOI: 10.3760/cma.j.cn121430-20250122-00053
Junqing Ma, Shanhong Zhang, Yanquan Hou, Xiaowei Miao, Hongrui Zhang, Zujun Song
<p><strong>Objective: </strong>To analyze the effect of serum magnesium on 90-day all-cause mortality in heart failure patients admitted to the intensive care unit (ICU).</p><p><strong>Methods: </strong>A retrospective cohort study was conducted using data from the Medical Information Mart for Intensive Care- III (MIMIC- III) database. Heart failure patients admitted to the ICU of Beth Israel Deaconess Medical Center between 2001 and 2012 were selected. Demographic characteristics, comorbidities, initial vital signs, and laboratory data were extracted. The outcome measure was 90-day all-cause mortality after ICU admission. Patients were divided into non-renal failure and renal failure groups based on the presence of renal failure. Univariate Logistic regression was used to analyze the relationship between potential confounding factors and the 90-day all-cause mortality. Multivariate Logistic regression was used to analyze the independent effect of serum magnesium on the 90-day all-cause mortality. A threshold effect analysis identified an inflection point for blood urea nitrogen (BUN) at 530 mg/L, and an interaction analysis examined the effect of BUN on the relationship between serum magnesium and the 90-day all-cause mortality.</p><p><strong>Results: </strong>A total of 1 162 ICU patients with heart failure were included, among which 695 were in the non-renal failure group and 467 in the renal failure group; 317 patients died (27.3%). Univariate analysis showed that serum magnesium was significantly associated with mortality in the renal failure group [odds ratio (OR) = 1.994, 95% confidence interval (95%CI) was 1.223-3.252, P < 0.05], but not in the non-renal failure group (OR = 1.098, 95%CI was 0.700-1.722, P > 0.05). Multivariate analysis showed that after adjusting for all selected confounding factors, serum magnesium was not significantly associated with mortality in the renal failure group (OR = 1.053, 95%CI was 0.519-2.132, P > 0.05), while in the non-renal failure group, serum magnesium showed a protective effect (OR = 0.460, 95%CI was 0.239-0.885, P < 0.05). The interaction analysis between BUN and serum magnesium showed that after adjusting for all selected confounding factors, there was an interaction between BUN and serum magnesium in the non-renal failure group (interaction P values were < 0.05), with a significant association between serum magnesium and mortality in the high BUN subgroup (OR = 0.082, 95%CI was 0.016-0.406, P < 0.05), but no significant association in the low BUN subgroup (OR = 0.946, 95%CI was 0.466-1.918, P > 0.05); there was no interaction between BUN and serum magnesium in the renal failure group (interaction P values were > 0.05), and there was no significant association between serum magnesium and mortality in both the high BUN subgroup and the low BUN subgroup (all P > 0.05).</p><p><strong>Conclusions: </strong>Renal function and BUN levels significantly modify the relationship between serum magnesium and 90
目的:分析血清镁对重症监护病房(ICU)心力衰竭患者90天全因死亡率的影响。方法:采用重症监护医学信息市场- III (MIMIC- III)数据库中的数据进行回顾性队列研究。选取2001 - 2012年Beth Israel Deaconess Medical Center ICU收治的心力衰竭患者。提取了人口统计学特征、合并症、初始生命体征和实验室数据。结局指标为ICU入院后90天全因死亡率。根据是否存在肾功能衰竭,将患者分为非肾功能衰竭组和肾功能衰竭组。采用单因素Logistic回归分析潜在混杂因素与90天全因死亡率的关系。采用多因素Logistic回归分析血清镁对90天全因死亡率的独立影响。阈值效应分析确定了530 mg/L血尿素氮(BUN)的拐点,交互作用分析检测了BUN对血清镁与90天全因死亡率之间关系的影响。结果:共纳入心力衰竭ICU患者1 162例,其中非肾衰组695例,肾衰组467例;死亡317例(27.3%)。单因素分析显示,肾功能衰竭组血清镁与死亡率有显著相关性[优势比(OR) = 1.994, 95%可信区间(95% ci)为1.223 ~ 3.252,P < 0.05],而非肾功能衰竭组无显著相关性(OR = 1.098, 95% ci为0.700 ~ 1.722,P < 0.05)。多因素分析显示,在调整所有选择的混杂因素后,血清镁与肾功能衰竭组死亡率无显著相关性(OR = 1.053, 95%CI为0.519 ~ 2.132,P < 0.05),而在非肾功能衰竭组,血清镁具有保护作用(OR = 0.460, 95%CI为0.239 ~ 0.885,P < 0.05)。BUN与血清镁的相互作用分析显示,在调整所有选择的混杂因素后,非肾功能衰竭组BUN与血清镁之间存在相互作用(相互作用P值< 0.05),高BUN亚组血清镁与死亡率之间存在显著相关性(OR = 0.082, 95%CI为0.016 ~ 0.406,P < 0.05),低BUN亚组血清镁与死亡率之间无显著相关性(OR = 0.946, 95%CI为0.466 ~ 1.918,P < 0.05);肾衰组BUN与血清镁无交互作用(交互P值为> 0.05),高BUN亚组和低BUN亚组血清镁与死亡率无显著相关性(P值均为> 0.05)。结论:肾功能和BUN水平可显著改变ICU心力衰竭患者血清镁与90天全因死亡率之间的关系。高BUN的非肾功能衰竭患者死亡率随血镁浓度的升高而显著降低,低BUN的非肾功能衰竭患者死亡率随血镁浓度的升高无显著变化。在肾衰竭患者中,无论BUN水平如何,血清镁浓度的变化对死亡率没有显著影响。
{"title":"[Effect of serum magnesium on mortality in intensive care unit patients with heart failure: a retrospective analysis based on the MIMIC-III database].","authors":"Junqing Ma, Shanhong Zhang, Yanquan Hou, Xiaowei Miao, Hongrui Zhang, Zujun Song","doi":"10.3760/cma.j.cn121430-20250122-00053","DOIUrl":"https://doi.org/10.3760/cma.j.cn121430-20250122-00053","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To analyze the effect of serum magnesium on 90-day all-cause mortality in heart failure patients admitted to the intensive care unit (ICU).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A retrospective cohort study was conducted using data from the Medical Information Mart for Intensive Care- III (MIMIC- III) database. Heart failure patients admitted to the ICU of Beth Israel Deaconess Medical Center between 2001 and 2012 were selected. Demographic characteristics, comorbidities, initial vital signs, and laboratory data were extracted. The outcome measure was 90-day all-cause mortality after ICU admission. Patients were divided into non-renal failure and renal failure groups based on the presence of renal failure. Univariate Logistic regression was used to analyze the relationship between potential confounding factors and the 90-day all-cause mortality. Multivariate Logistic regression was used to analyze the independent effect of serum magnesium on the 90-day all-cause mortality. A threshold effect analysis identified an inflection point for blood urea nitrogen (BUN) at 530 mg/L, and an interaction analysis examined the effect of BUN on the relationship between serum magnesium and the 90-day all-cause mortality.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 1 162 ICU patients with heart failure were included, among which 695 were in the non-renal failure group and 467 in the renal failure group; 317 patients died (27.3%). Univariate analysis showed that serum magnesium was significantly associated with mortality in the renal failure group [odds ratio (OR) = 1.994, 95% confidence interval (95%CI) was 1.223-3.252, P &lt; 0.05], but not in the non-renal failure group (OR = 1.098, 95%CI was 0.700-1.722, P &gt; 0.05). Multivariate analysis showed that after adjusting for all selected confounding factors, serum magnesium was not significantly associated with mortality in the renal failure group (OR = 1.053, 95%CI was 0.519-2.132, P &gt; 0.05), while in the non-renal failure group, serum magnesium showed a protective effect (OR = 0.460, 95%CI was 0.239-0.885, P &lt; 0.05). The interaction analysis between BUN and serum magnesium showed that after adjusting for all selected confounding factors, there was an interaction between BUN and serum magnesium in the non-renal failure group (interaction P values were &lt; 0.05), with a significant association between serum magnesium and mortality in the high BUN subgroup (OR = 0.082, 95%CI was 0.016-0.406, P &lt; 0.05), but no significant association in the low BUN subgroup (OR = 0.946, 95%CI was 0.466-1.918, P &gt; 0.05); there was no interaction between BUN and serum magnesium in the renal failure group (interaction P values were &gt; 0.05), and there was no significant association between serum magnesium and mortality in both the high BUN subgroup and the low BUN subgroup (all P &gt; 0.05).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;Renal function and BUN levels significantly modify the relationship between serum magnesium and 90","PeriodicalId":24079,"journal":{"name":"Zhonghua wei zhong bing ji jiu yi xue","volume":"37 12","pages":"1125-1132"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145918592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Zhonghua wei zhong bing ji jiu yi xue
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1